Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Genet Test Mol Biomarkers ; 22(1): 55-61, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29227750

RESUMEN

AIMS: The etiology of infertility is still unknown in almost half of all male infertility patients. In sperm, DNA condensation differs from somatic and female gamete cells, with the protamine (PRM) gene and its transcription factor, Y-box binding protein 2 (YBX2), playing key roles in making the structure more compact. Protamine polymorphisms have been studied in different populations, but various results have been acquired. MATERIALS AND METHODS: In our study, we examined, for the first time in a Turkish population, the association between protamine gene alleles (PRM1 c.-190C>A, PRM1 c.197G>T, and PRM2 c.248C>T), and YBX2 (c.187T>C and c.1095 + 16A>G) and male infertility. This was accomplished using polymerase chain reaction-restriction fragment length polymorphism analyses of 100 infertile and 100 fertile Turkish men. Sperm DNA fragmentation analysis was performed using the Comet technique. RESULTS: We found that the AA and CA genotypes of the PRM1 c.-190C>A polymorphism had a significant association with infertility (p < 0.001) and the AA genotype was also highly significantly associated with high sperm DNA damage (p < 0.001). CONCLUSION: This study demonstrates that the PRM1 c.-190C>A polymorphism is associated with sperm DNA fragmentation, which may impact male infertility in the Turkish population. Further research with larger groups and in various other study populations will be required to clarify the impact of protamine and YBX2 gene polymorphisms on male infertility.


Asunto(s)
Infertilidad Masculina/genética , Protaminas/genética , Proteínas de Unión al ARN/genética , Adulto , Alelos , Frecuencia de los Genes , Genotipo , Humanos , Masculino , Polimorfismo de Nucleótido Simple , Protaminas/metabolismo , Proteínas de Unión al ARN/metabolismo , Espermatozoides/fisiología
2.
Mater Sci Eng C Mater Biol Appl ; 67: 590-598, 2016 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-27287158

RESUMEN

Nanoporous anodized alumina membranes (AAMs) have numerous biomedical applications spanning from biosensors to controlled drug delivery and implant coatings. Although the use of AAM as an alternative bone implant surface has been successful, its potential as a neural implant coating remains unclear. Here, we introduce conductive and nerve growth factor-releasing AAM substrates that not only provide the native nanoporous morphology for cell adhesion, but also induce neural differentiation. We recently reported the fabrication of such conductive membranes by coating AAMs with a thin C layer. In this study, we investigated the influence of electrical stimulus, surface topography, and chemistry on cell adhesion, neurite extension, and density by using PC 12 pheochromocytoma cells in a custom-made glass microwell setup. The conductive AAMs showed enhanced neurite extension and generation with the electrical stimulus, but cell adhesion on these substrates was poorer compared to the naked AAMs. The latter nanoporous material presents chemical and topographical features for superior neuronal cell adhesion, but, more importantly, when loaded with nerve growth factor, it can provide neurite extension similar to an electrically stimulated CAAM counterpart.


Asunto(s)
Óxido de Aluminio/química , Conductividad Eléctrica , Membranas Artificiales , Factor de Crecimiento Nervioso , Animales , Adhesión Celular/efectos de los fármacos , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacocinética , Preparaciones de Acción Retardada/farmacología , Factor de Crecimiento Nervioso/química , Factor de Crecimiento Nervioso/farmacocinética , Factor de Crecimiento Nervioso/farmacología , Células PC12 , Ratas
3.
Ophthalmic Res ; 40(1): 32-4, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18025834

RESUMEN

AIMS: To determine the association between the angiotensin-converting enzyme insertion/deletion (I/D) polymorphism and pseudoexfoliation (PEX) in Turkish patients. METHODS: This prospective study consisted of 89 patients with PEX, and 120 controls. The I/D polymorphism of the angiotensin-converting enzyme gene was measured with the use of the polymerase chain reaction method. RESULTS: The distribution of the polymorphism was not significantly different in cases with PEX and controls. The frequencies of the I and D alleles were not significantly different between the groups. CONCLUSION: According to our findings, I/D polymorphism in the angiotensin-converting enzyme gene does not play any role in the pathogenesis of PEX.


Asunto(s)
Síndrome de Exfoliación/genética , Peptidil-Dipeptidasa A/genética , Polimorfismo Genético , Anciano , Elementos Transponibles de ADN , Femenino , Eliminación de Gen , Frecuencia de los Genes , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa
4.
J Thromb Thrombolysis ; 19(1): 61-3, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15976969

RESUMEN

BACKGROUND: Tissue-plasminogen activator is a key protein of fibrinolytic system. In recent years the relation between t-PA, its genetic polymorphisms and arterial or venous thrombosis were investigated in different populations. The aim of this study is to investigate the role of t-PA gene polymorphism in Turkish venous thromboembolism (VTE) patients. METHODS: A case-control study was performed. We investigated the t-PA insertion/deletion (I/D) polymorphism in 93 VTE patients and 146 controls without VTE. Recurrent cases and documented risk factors for PTE were recorded. RESULTS: Cases and controls did not differ with respect to the different t-PA genotypes. The prevalence of I allele was 44.1%, 44.5% in cases and controls respectively (OR = 0.95, 95% CI: 0.78-1.24, p > 0.05). Different t-PA genotypes had no effect on recurrent disease. No gender difference was observed with respect to the different t-PA genotypes. There was no significant difference for genotype frequency between PTE patients with documented risk factors and unprovoked cases. CONCLUSIONS: In conclusion there was no association between t-PA genotype and VTE in this group of Turkish population. It was also found that genotype frequencies for t-PA in both VTE and control subjects seems different from those reported from western part of the world. ABBREVIATED ABSTRACT: The aim of this study is to investigate the role of t-PA gene polymorphism in Turkish VTE patients. We investigated 93 VTE patients and 146 controls without VTE. Cases and controls did not differ with respect to the different t-PA genotypes. The prevalence of I allele was 44.1%, 44.5% in cases and controls respectively (OR = 0.95, 95% CI: 0.78-1.24, p > 0.05). Different t-PA genotypes had no effect on recurrent disease. No gender difference was observed with respect to the different t-PA genotypes. There was no significant difference for genotype frequency between PTE patients with documented risk factors and unprovoked cases. In conclusion there was no association between t-PA genotype and VTE in this group of Turkish population. It was also found that genotype frequencies for t-PA in both VTE and control subjects seems different from those reported from western part of the world.


Asunto(s)
Polimorfismo Genético , Tromboembolia/genética , Activador de Tejido Plasminógeno/genética , Trombosis de la Vena/genética , Secuencia de Bases , Estudios de Casos y Controles , Cartilla de ADN , Femenino , Fibrinólisis/genética , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Valores de Referencia , Factores de Riesgo , Tromboembolia/epidemiología , Turquía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...